Rani Therapeutics Holdings

Rani Therapeutics Holdings, Inc. operates as a clinical stage bio-therapeutics company providing technologies to enable the development of orally administered biologics. It offers RaniPill capsule, an orally ingestible pill for the administration of a broad range of biologics. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Earnings data Q1 2026

Earnings data Q2 2026

Rani Therapeutics excels in drug delivery innovation and clinical progress

Rani Therapeutics demonstrated strong performance in 2023 with positive Phase I results and successful oral delivery achievements, showcasing its innovative capabilities.
While facing challenges in negotiations and pipeline development, Rani has strengths in transformative technology and clinical expertise to navigate the competitive landscape.
With opportunities to expand drug delivery capabilities and strategic collaborations, Rani Therapeutics is poised for growth and advancement in the pharmaceutical sector.

Rani Therapeutics excels in Q4 with RaniPill technology innovations

Rani Therapeutics Holdings demonstrated strong performance and innovation in Q4 2024, showcasing the potential of their RaniPill technology in oral biologics delivery. While facing challenges in tolerability, competition, and regulatory hurdles, Rani's strategic strengths in product development and partnerships position them for future growth. With a focus on addressing challenges, leveraging opportunities, and driving innovation, Rani is poised to navigate the evolving biopharmaceutical landscape successfully.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.